Prophase Labs Inc reports results for the quarter - Earnings Summary

Prophase Labs

13/11/2024 15:24

* Prophase Labs Inc  PRPH.OQ  reported a quarterly adjusted
loss
of 35 cents​​ per share for the quarter , lower than the same
quarter last year, when the company reported EPS of -30 cents. 
The lone analyst forecast for the quarter was for earnings of 4
cents per share. 
    * Revenue fell 62.4% to $3.15 million from a year ago;
analysts
expected $23.85 million. 
    * Prophase Labs Inc's reported EPS for the quarter was a
loss
of 35 cents​.
    * Prophase Labs Inc shares had fallen by 69.5% this
quarter and
lost 83.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 123.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Prophase Labs Inc
is 18.50 
This summary was machine generated from LSEG data November 13 at
03:23 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.04           -0.35          Missed
 Jun. 30 2024      -0.24          -0.33          Missed
 Mar. 31 2024      -0.28          -0.07          Beat
 Dec. 31 2023      -0.26          -0.51          Missed